Status:
NOT_YET_RECRUITING
The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients
Lead Sponsor:
Terry Ponich
Conditions:
Ulcerative Colitis (UC)
IBD (Inflammatory Bowel Disease)
Eligibility:
All Genders
18-85 years
Phase:
PHASE1
Brief Summary
The aim of this clinical trial is to gain a better understanding of the effect of Vitamin D supplementation on disease activity and overall health. The main questions it aims to answer are: 1. What p...
Detailed Description
Upon investigating the literature, despite there being a lot of medication compliance research, there was not much research catered to IBD patient medication management specifically. Vitamin D supple...
Eligibility Criteria
Inclusion
- Adults Aged 18-85
- Diagnosis of IBD (Ulcerative Colitis or Crohn's Disease) within the patient's records based on standard clinical, endoscopic, and radiologic criteria.
- Patients within outpatient gastroenterology clinics at Victoria Hospital and St. Joseph's Hospital with follow-up appointments within the next 2 years (ongoing IBD care).
- Participants must have the ability to read, comprehend, and voluntarily provide informed consent without assistance.
Exclusion
- Those who do not meet the inclusion criteria.
- Those with any concurrent diagnosis of disease that may affect calcium or Vitamin D metabolism (i.e., rheumatoid arthritis or other inflammatory joint disease, thyroid disease, parathyroid disease, primary bone disease, granulomatous disease, sarcoidosis, lymphoma).
- Those with either renal dysfunction (serum creatinine \>0.150 mmol/L) or receiving dialysis were excluded, patients with chronic liver disease, and hypercalcemia (\>2.65mmol/L).
- Those using oral corticosteroids for the management of any disease other than IBD.
- Those with a history of Vitamin D or calcium supplementation within 6 months prior to the trial.
- Those who were seen once by the gastroenterology team but never followed up (no ongoing IBD care).
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT07177157
Start Date
October 1 2025
End Date
March 1 2027
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Victoria Hospital - London Health Sciences Centre
London, Ontario, Canada, N6A 5A5